miR-142-3p as Potential Biomarker of Synaptopathy in MS

Clinical trial NCT03999788 · UNKNOWN

Trial details

NCT number: NCT03999788
Sponsor: Neuromed IRCCS
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Sclerosis Spasticity

Start date: 2019-12-10
Primary completion: 2024-12-28
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.